Question 1

What specific tests will be done to check for EGFR mutations?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of erlotinib and gemcitabine differ from standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of erlotinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib clinical trial (NCT01608841). Contact the study team or your healthcare provider for specific answers.

What this study is about